Anavex Life Sciences (AVXL) EBIT Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | 28.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.33% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | -5.09% |
| Mar 31, 2025 | -2.80% |
| Dec 31, 2024 | -5.05% |
| Sep 30, 2024 | -7.23% |
| Jun 30, 2024 | -12.92% |
| Mar 31, 2024 | -15.81% |
| Dec 31, 2023 | -13.43% |
| Sep 30, 2023 | -28.57% |
| Jun 30, 2023 | -27.80% |
| Mar 31, 2023 | -25.16% |
| Dec 31, 2022 | -32.71% |
| Sep 30, 2022 | -39.75% |
| Jun 30, 2022 | -24.20% |
| Mar 31, 2022 | -16.97% |
| Dec 31, 2021 | -19.26% |
| Sep 30, 2021 | -27.71% |
| Jun 30, 2021 | -52.68% |
| Mar 31, 2021 | -19.83% |
| Dec 31, 2020 | -24.40% |
| Sep 30, 2020 | -5.00% |
| Jun 30, 2020 | -21.65% |
| Mar 31, 2020 | -67.52% |
| Dec 31, 2019 | -28.32% |
| Sep 30, 2019 | 4.87% |
| Jun 30, 2019 | -42.77% |